Diagnosis and Treatment of Lung Cancer

Displaying 1 - 20 of 20CSV
Spira, A., Girard, N., Krebs, M., Park, K., Shu, C., Dougherty, L., & Cho, B. C. (2023). A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab. Future Oncology, 19(33), 2213–2225. https://doi.org/10.2217/fon-2023-0284
Publication Date
Saqi, A., Liu, Y., Politis, M. G., Salvatore, M., & Jambawalikar, S. (2024). Combined expert-in-the-loop—random forest multiclass segmentation U-net based artificial intelligence model: evaluation of non-small cell lung cancer in fibrotic and non-fibrotic microenvironments. Journal of Translational Medicine, 22(1). https://doi.org/10.1186/s12967-024-05394-2
Publication Date
Tarchi, S. M., Salvatore, M., Lichtenstein, P., Sekar, T., Capaccione, K., Luk, L., Shaish, H., Makkar, J., Desperito, E., Leb, J., Navot, B., Goldstein, J., Laifer, S., Beylergil, V., Ma, H., Jambawalikar, S., Aberle, D., D’Souza, B., Bentley-Hibbert, S., & Marin, M. P. (2024). Radiology of fibrosis. Part I: Thoracic organs. Journal of Translational Medicine, 22(1). https://doi.org/10.1186/s12967-024-05244-1
Publication Date
Chen, L. N., Stanifer, B. P., Sonett, J. R., & Shu, C. A. (2024). Advancing neoadjuvant immunotherapy in non-small cell lung cancer (NSCLC): commentary on the Lung Cancer Mutation Consortium 3 trial (LCMC3). AME Clinical Trials Review, 2, 37–37. https://doi.org/10.21037/actr-24-13
Publication Date
Salvatore, M. M., Liu, Y., Peng, B., Hsu, H. Y., Saqi, A., Tsai, W.-Y., Leu, C.-S., & Jambawalikar, S. (2024). Comparison of lung cancer occurring in fibrotic versus non-fibrotic lung on chest CT. Journal of Translational Medicine, 22(1). https://doi.org/10.1186/s12967-023-04645-y
Publication Date
Liu, Y., Hsu, H. Y., Lin, T., Peng, B., Saqi, A., Salvatore, M. M., & Jambawalikar, S. (2024). Lung nodule malignancy classification with associated pulmonary fibrosis using 3D attention-gated convolutional network with CT scans. Journal of Translational Medicine, 22(1). https://doi.org/10.1186/s12967-023-04798-w
Publication Date
Lee, J. M., Toloza, E. M., Pass, H. I., Johnson, B. E., Heymach, J. V., Sholl, L., Saqi, A., Travis, W. D., Wistuba, I., Lin, J., Kris, M. G., Spira, A. I., Shu, C. A., Saltos, A. N., Ding, B., Schulze, K., Zhu, Q., Ngiam, C., Bara, I., & Chaft, J. E. (2023). P2.01-06 NAUTIKA1 Study: Preliminary Efficacy and Safety Data with Neoadjuvant Alectinib in Patients with Stage IB-III ALK+ NSCLC. Journal of Thoracic Oncology, 18(11), S297–S298. https://doi.org/10.1016/j.jtho.2023.09.511
Publication Date
Leighl, N., Cho, B. C., Hiret, S., Han, J.-Y., Lee, K. H., Llacer Perez, C., Krebs, M. G., De Braud, F., Haura, E., Sanborn, R. E., Yang, J. C.-H., Shu, C. A., Goto, K., Nishio, M., Zhao, J., Wang, Z., Tomasini, P., Felip, E., Goldman, J. W., … Spira, A. I. (2023). OA21.04 Amivantamab in Patients with Advanced NSCLC and MET Exon 14 Skipping Mutation: Results from the CHRYSALIS Study. Journal of Thoracic Oncology, 18(11), S93–S94. https://doi.org/10.1016/j.jtho.2023.09.105
Publication Date
Rayn, K., Clark, R., Magliari, A., Jeffers, B., Lavrova, E., Lozano, I. V., Price, M. J., Rosa, L., & Horowitz, D. P. (2023). Scorecards: Quantifying Dosimetric Plan Quality in Pancreatic Ductal Adenocarcinoma Stereotactic Body Radiation Therapy. Advances in Radiation Oncology, 8(6), 101295. https://doi.org/10.1016/j.adro.2023.101295
Publication Date
Dacic, S., Travis, W., Redman, M., Saqi, A., Cooper, W. A., Borczuk, A., Chung, J.-H., Glass, C., Lopez, J. M., Roden, A. C., Sholl, L., Weissferdt, A., Posadas, J., Walker, A., Zhu, H., Wijeratne, M. T., Connolly, C., Wynes, M., Bota-Rabassedas, N., … Wistuba, I. (2023). International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy. Journal of Thoracic Oncology, 18(10), 1290–1302. https://doi.org/10.1016/j.jtho.2023.07.017
Publication Date
Saber A, A., Morshed, A., Bangchen, W., Weining, Z., Chi, L., Apar Kishor, G., Vinicius, E., Alissa, M., Tony JC, W., Simon K, C., Michael, B., & Chi, Z. (2023). The Impacts of Angiotensin Receptor Blockers (ARBs) or Angiotensin-Converting Enzyme Inhibitors (ACEIs) on Patients with Stereotactic Body Radiation Therapy (SBRT) for Early-Stage NSCLC. Journal of Radiology and Oncology, 7(2), 033–041. https://doi.org/10.29328/journal.jro.1001050
Publication Date
Pan, Y., Wang, D., Chaudhary, M. F. A., Shao, W., Gerard, S. E., Durumeric, O. C., Bhatt, S. P., Barr, R. G., Hoffman, E. A., Reinhardt, J. M., & Christensen, G. E. (2022). Robust Measures of Image-Registration-Derived Lung Biomechanics in SPIROMICS. Journal of Imaging, 8(11), 309. https://doi.org/10.3390/jimaging8110309
Publication Date
Dercle, L., Gomez, D., Zhao, B., Kelly, K., Herbst, R. S., Redman, M. W., Gandara, D. R., & Schwartz, L. H. (2022). P2.12-03 External Validation of a Novel CT-Based Prognostic Radiomic Signature in Patients with Metastatic NSCLC in SWOG S0819 Phase III Randomized Trial. Journal of Thoracic Oncology, 17(9), S152. https://doi.org/10.1016/j.jtho.2022.07.251
Publication Date
Lopci, E., Hicks, R. J., Dimitrakopoulou-Strauss, A., Dercle, L., Iravani, A., Seban, R. D., Sachpekidis, C., Humbert, O., Gheysens, O., Glaudemans, A. W. J. M., Weber, W., Wahl, R. L., Scott, A. M., Pandit-Taskar, N., & Aide, N. (2022). Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0. European Journal of Nuclear Medicine and Molecular Imaging, 49(7), 2323–2341. https://doi.org/10.1007/s00259-022-05780-2
Publication Date
Olazagasti, C., Ehrlich, M., Kohn, N., Aviles, K., Hoilett, A., & Seetharamu, N. (2022). Missed Opportunities? An Observational Analysis of Lung Cancer Screening Utilization Amongst Patients With Lung Cancer. Cancer Control, 29. https://doi.org/10.1177/10732748221077959
Publication Date